Tianqing Chu

2 articles listing Tianqing Chu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Cadonilimab plus chemotherapy as first-line treatment in PD-L1-negative advanced non-small cell lung cancer: a phase II clinical trial Nature Communications
2. Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis Nature Communications